Clinical trial
AMP as a Better Delivery System of Adenosine
NCT00179010 · Vanderbilt University Medical Center, Other · Terminated
Key facts
| NCT number | NCT00179010 |
|---|---|
| Title | AMP as a Better Delivery System of Adenosine |
| Official title | Use of AMP to Improve Tissue Delivery of Adenosine |
| Lead sponsor | Vanderbilt University Medical Center, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ischemia |
| Intervention type | Drug |
| Interventions | Adenosine, Adenosine Mono Phosphate (AMP) |
| Enrollment | 13 |
| Start date | Oct 1, 2003 |
| Primary completion | Jan 1, 2017 |
| Completion | Jan 1, 2017 |
| First posted | Sep 15, 2005 |
| Last update posted | May 7, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: